Similar articles for PMID: 24679654

Year	Number of Results
2004	1
2006	3
2007	4
2008	2
2009	5
2010	7
2011	7
2012	10
2013	6
2014	10
2015	9
2016	11
2017	5
2018	11
2019	8
2020	13
2021	15
2022	16
2023	3
2024	0

1

Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.

Koyama K, Ohshima N, Suzuki J, Kawashima M, Takeda K, Ando T, Sato R, Nagai H, Matsui H, Ohta K. Koyama K, et al. J Infect Chemother. 2014 Jun;20(6):375-9. doi: 10.1016/j.jiac.2014.02.003. Epub 2014 Mar 26. J Infect Chemother. 2014. PMID: 24679654

2

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.

Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Felton TW, et al. Clin Infect Dis. 2010 Dec 15;51(12):1383-91. doi: 10.1086/657306. Epub 2010 Nov 5. Clin Infect Dis. 2010. PMID: 21054179

3

Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.

Bongomin F, Maguire N, Moore CB, Felton T, Rautemaa-Richardson R. Bongomin F, et al. Mycoses. 2019 Mar;62(3):217-222. doi: 10.1111/myc.12885. Epub 2019 Jan 15. Mycoses. 2019. PMID: 30570179

4

Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.

Saito T, Fujiuchi S, Tao Y, Sasaki Y, Ogawa K, Suzuki K, Tada A, Kuba M, Kato T, Kawabata M, Kurashima A, Sakatani M; NHO Pulmonary Fungosis Research Group. Saito T, et al. Infection. 2012 Dec;40(6):661-7. doi: 10.1007/s15010-012-0322-x. Epub 2012 Sep 7. Infection. 2012. PMID: 22956473

5

Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry.

Camara B, Reymond E, Saint-Raymond C, Roth H, Brenier-Pinchart MP, Pinel C, Cadranel J, Ferretti G, Pelloux H, Pison C; Grenoble Aspergillus Committee. Camara B, et al. Clin Respir J. 2015 Jan;9(1):65-73. doi: 10.1111/crj.12105. Epub 2014 Feb 17. Clin Respir J. 2015. PMID: 24406138

6

Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.

Sambatakou H, Dupont B, Lode H, Denning DW. Sambatakou H, et al. Am J Med. 2006 Jun;119(6):527.e17-24. doi: 10.1016/j.amjmed.2005.11.028. Am J Med. 2006. PMID: 16750972 Clinical Trial.

7

Clinical characteristics and prognosis of chronic pulmonary aspergillosis.

Ohba H, Miwa S, Shirai M, Kanai M, Eifuku T, Suda T, Hayakawa H, Chida K. Ohba H, et al. Respir Med. 2012 May;106(5):724-9. doi: 10.1016/j.rmed.2012.01.014. Epub 2012 Feb 19. Respir Med. 2012. PMID: 22349065 Free article.

8

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.

Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P. Cadranel J, et al. Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3231-9. doi: 10.1007/s10096-012-1690-y. Epub 2012 Jul 11. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22782438 Free PMC article. Clinical Trial.

9

The spectrum of pulmonary aspergillosis.

Kanj A, Abdallah N, Soubani AO. Kanj A, et al. Respir Med. 2018 Aug;141:121-131. doi: 10.1016/j.rmed.2018.06.029. Epub 2018 Jul 3. Respir Med. 2018. PMID: 30053957 Free article. Review.

10

Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.

Keir GJ, Garfield B, Hansell DM, Loebinger MR, Wilson R, Renzoni EA, Wells AU, Maher TM. Keir GJ, et al. Thorax. 2014 Mar;69(3):287-8. doi: 10.1136/thoraxjnl-2013-203988. Epub 2013 Sep 12. Thorax. 2014. PMID: 24029745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year